Can Celexa and Nortriptyline Be Taken Together?
Yes, a patient can take Celexa (citalopram) and nortriptyline together, but this combination requires careful monitoring due to the risk of serotonin syndrome and potential QT interval prolongation. 1, 2
Key Safety Considerations
Serotonin Syndrome Risk
The combination of citalopram (an SSRI) with nortriptyline (a tricyclic antidepressant with serotonergic properties) creates a moderate risk for serotonin syndrome. Caution should be exercised when combining two or more non-MAOI serotonergic drugs, including SSRIs and TCAs. 1
The approach to safe combination therapy includes:
- Start the second serotonergic drug at a low dose
- Increase the dose slowly
- Monitor closely for symptoms, especially in the first 24 to 48 hours after dosage changes 1
Watch for serotonin syndrome symptoms:
- Mental status changes (confusion, agitation, anxiety)
- Neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity)
- Autonomic hyperactivity (hypertension, tachycardia, diaphoresis, vomiting, diarrhea)
- Advanced symptoms: fever, seizures, arrhythmias, unconsciousness 1
QT Prolongation Concerns
Both citalopram and nortriptyline can prolong the QT interval, creating additive cardiac risk. 3, 4
Specific considerations:
- Citalopram carries higher QT prolongation risk among SSRIs (highest with citalopram and escitalopram, negligible with paroxetine and sertraline) 3
- Citalopram may cause QT prolongation associated with Torsade de Pointes, ventricular tachycardia, and sudden death at daily doses exceeding 40 mg/day 1
- TCAs including nortriptyline are associated with increased cardiac arrest risk (OR = 1.69) 4
- SSRIs are associated with cardiac arrest risk (OR = 1.21) 4
When combining these medications, consider baseline and follow-up ECGs, especially if:
- Patient has other QT-prolonging risk factors
- Patient is elderly (>60 years)
- Patient has structural heart disease
- Patient is taking other QT-prolonging medications
- Patient has electrolyte disturbances 3, 4
Pharmacokinetic Interactions
Citalopram has minimal effect on CYP450 isoenzymes compared with other SSRIs and has a lower propensity for drug interactions. 1 Research evidence supports this: a case study demonstrated that adding citalopram 40-60 mg/day to amitriptyline 75 mg/day had no effect on tricyclic plasma levels 5. This suggests citalopram is less likely than fluoxetine or paroxetine to increase nortriptyline levels through CYP2D6 inhibition.
However, one case report documented severe sedation when melatonin was added to a regimen including both citalopram and nortriptyline, suggesting potential for pharmacokinetic interactions under certain circumstances 6.
Clinical Evidence Supporting Combination Use
Research demonstrates that combined amitriptyline and citalopram therapy can be beneficial for patients who don't respond to monotherapy. 7 In a study of patients with comorbid depression, migraine, and tension-type headache, those who failed monotherapy with either drug showed substantial improvement when both were combined, without producing major side effects such as serotonergic syndrome 7.
Additionally, switching between nortriptyline and escitalopram (a closely related SSRI) has been shown effective for patients experiencing side effects or non-response, with significant MADRS score improvements in both switching directions 8.
Practical Management Algorithm
When prescribing this combination:
Assess baseline cardiac risk:
Start conservatively:
- Begin with low doses of both medications
- If adding one to the other, start the second drug at the lowest available dose 1
Titrate slowly:
Monitor intensively during initiation:
Maintain appropriate dosing limits:
Ongoing monitoring:
Common Pitfalls to Avoid
- Don't combine with MAOIs - absolute contraindication with 14-day washout period required 2
- Don't ignore cardiac risk factors - elderly patients and those with heart disease require closer monitoring 3, 4
- Don't use high doses of citalopram - stay within FDA-recommended limits to minimize QT risk 1, 4
- Don't overlook drug interactions - be cautious with other serotonergic drugs (tramadol, triptans, linezolid) 2
- Don't forget bleeding risk - both drugs increase bleeding risk, especially with NSAIDs, aspirin, or warfarin 1, 2
Alternative Considerations
If cardiac risk is prohibitive or serotonin syndrome concerns are high, consider alternative SSRIs with lower QT risk (sertraline, paroxetine) or alternative antidepressants with different mechanisms 3, 12. However, the evidence suggests this combination can be used safely with appropriate precautions and monitoring.